Charbel Chidiac, Pallavi Menon, Mark B Slidell, Shaun M Kunisaki, Alejandro V Garcia, Daniel S Rhee
{"title":"儿童癌症的不公平:揭示健康对生存的社会决定因素的影响。","authors":"Charbel Chidiac, Pallavi Menon, Mark B Slidell, Shaun M Kunisaki, Alejandro V Garcia, Daniel S Rhee","doi":"10.1002/pbc.31742","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The implications of sociodemographic factors across a wide range of pediatric cancers remain unclear. This study aims to assess the impact of social determinants of health (SDOH) on the survival rates of children diagnosed with cancer.</p><p><strong>Methods: </strong>This retrospective cohort study included children <18 years with cancer in the National Cancer Database (2004-2020). Cancers included were central nervous system (CNS) tumors, leukemia, lymphoma, and non-CNS solid tumors. The primary outcome was five-year overall survival (5-OS). Kaplan-Meier curves and multivariable Cox proportional regression were employed.</p><p><strong>Results: </strong>Of 132,076 children (median age 8 years), 14.8% had CNS tumors, 47.4% leukemia/lymphoma, and 37.8% had non-CNS solid tumors. The median follow-up was 67.3 months. 5-OS was lower in Black (78.9% vs. 84.9%, p < 0.001) and Hispanic (82.1% vs. 84.3%, p < 0.001) children, and those publicly insured (82.1%) and noninsured (80.2%) compared with privately insured (85.8%) (p < 0.001). On multivariable analysis, factors associated with increased hazard of death were Black race (aHR 1.28, 95% CI 1.23-1.34), Hispanic ethnicity (aHR 1.08, 95% CI 1.03-1.12), areas with <93% parental high school graduation (aHR 1.20, 95% CI 1.14-1.25), median household income <$63,331 (aHR 1.11, 95% CI 1.06-1.16), nonprivate insurance (aHR 1.16, 95%CI 1.12-1.20), no insurance (aHR 1.36, 95% CI 1.24-1.49), living in rural/urban areas (aHR 1.05, 95% CI 1.01-1.10) and living ≥60 miles from the treating facility (aHR 1.20, 95% CI 1.15-1.24).</p><p><strong>Conclusions: </strong>SDOH are associated with disparities in pediatric cancer survival rates. Targeted strategies to enhance care for Black and Hispanic children, as well as those with limited access due to insurance and travel distance, are essential for achieving equitable outcomes for all pediatric cancer patients.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e31742"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inequities in Pediatric Cancer: Unveiling the Impact of Social Determinants of Health on Survival.\",\"authors\":\"Charbel Chidiac, Pallavi Menon, Mark B Slidell, Shaun M Kunisaki, Alejandro V Garcia, Daniel S Rhee\",\"doi\":\"10.1002/pbc.31742\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The implications of sociodemographic factors across a wide range of pediatric cancers remain unclear. This study aims to assess the impact of social determinants of health (SDOH) on the survival rates of children diagnosed with cancer.</p><p><strong>Methods: </strong>This retrospective cohort study included children <18 years with cancer in the National Cancer Database (2004-2020). Cancers included were central nervous system (CNS) tumors, leukemia, lymphoma, and non-CNS solid tumors. The primary outcome was five-year overall survival (5-OS). Kaplan-Meier curves and multivariable Cox proportional regression were employed.</p><p><strong>Results: </strong>Of 132,076 children (median age 8 years), 14.8% had CNS tumors, 47.4% leukemia/lymphoma, and 37.8% had non-CNS solid tumors. The median follow-up was 67.3 months. 5-OS was lower in Black (78.9% vs. 84.9%, p < 0.001) and Hispanic (82.1% vs. 84.3%, p < 0.001) children, and those publicly insured (82.1%) and noninsured (80.2%) compared with privately insured (85.8%) (p < 0.001). On multivariable analysis, factors associated with increased hazard of death were Black race (aHR 1.28, 95% CI 1.23-1.34), Hispanic ethnicity (aHR 1.08, 95% CI 1.03-1.12), areas with <93% parental high school graduation (aHR 1.20, 95% CI 1.14-1.25), median household income <$63,331 (aHR 1.11, 95% CI 1.06-1.16), nonprivate insurance (aHR 1.16, 95%CI 1.12-1.20), no insurance (aHR 1.36, 95% CI 1.24-1.49), living in rural/urban areas (aHR 1.05, 95% CI 1.01-1.10) and living ≥60 miles from the treating facility (aHR 1.20, 95% CI 1.15-1.24).</p><p><strong>Conclusions: </strong>SDOH are associated with disparities in pediatric cancer survival rates. Targeted strategies to enhance care for Black and Hispanic children, as well as those with limited access due to insurance and travel distance, are essential for achieving equitable outcomes for all pediatric cancer patients.</p>\",\"PeriodicalId\":19822,\"journal\":{\"name\":\"Pediatric Blood & Cancer\",\"volume\":\" \",\"pages\":\"e31742\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Blood & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pbc.31742\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Blood & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pbc.31742","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:社会人口学因素对各种儿科癌症的影响尚不清楚。本研究旨在评估健康的社会决定因素(SDOH)对诊断患有癌症的儿童存活率的影响。结果:在132076名儿童(中位年龄8岁)中,14.8%患有中枢神经系统肿瘤,47.4%患有白血病/淋巴瘤,37.8%患有非中枢神经系统实体瘤。中位随访时间为67.3个月。黑人儿童(78.9% vs. 84.9%, p < 0.001)和西班牙裔儿童(82.1% vs. 84.3%, p < 0.001)以及公共保险儿童(82.1%)和非保险儿童(80.2%)的5-OS低于私人保险儿童(85.8%)(p < 0.001)。在多变量分析中,与死亡风险增加相关的因素是黑人种族(aHR 1.28, 95% CI 1.23-1.34),西班牙裔种族(aHR 1.08, 95% CI 1.03-1.12),结论是:SDOH与儿童癌症存活率的差异有关。加强对黑人和西班牙裔儿童以及因保险和旅行距离而无法获得治疗的儿童的护理的有针对性的战略,对于实现所有儿童癌症患者的公平结局至关重要。
Inequities in Pediatric Cancer: Unveiling the Impact of Social Determinants of Health on Survival.
Background: The implications of sociodemographic factors across a wide range of pediatric cancers remain unclear. This study aims to assess the impact of social determinants of health (SDOH) on the survival rates of children diagnosed with cancer.
Methods: This retrospective cohort study included children <18 years with cancer in the National Cancer Database (2004-2020). Cancers included were central nervous system (CNS) tumors, leukemia, lymphoma, and non-CNS solid tumors. The primary outcome was five-year overall survival (5-OS). Kaplan-Meier curves and multivariable Cox proportional regression were employed.
Results: Of 132,076 children (median age 8 years), 14.8% had CNS tumors, 47.4% leukemia/lymphoma, and 37.8% had non-CNS solid tumors. The median follow-up was 67.3 months. 5-OS was lower in Black (78.9% vs. 84.9%, p < 0.001) and Hispanic (82.1% vs. 84.3%, p < 0.001) children, and those publicly insured (82.1%) and noninsured (80.2%) compared with privately insured (85.8%) (p < 0.001). On multivariable analysis, factors associated with increased hazard of death were Black race (aHR 1.28, 95% CI 1.23-1.34), Hispanic ethnicity (aHR 1.08, 95% CI 1.03-1.12), areas with <93% parental high school graduation (aHR 1.20, 95% CI 1.14-1.25), median household income <$63,331 (aHR 1.11, 95% CI 1.06-1.16), nonprivate insurance (aHR 1.16, 95%CI 1.12-1.20), no insurance (aHR 1.36, 95% CI 1.24-1.49), living in rural/urban areas (aHR 1.05, 95% CI 1.01-1.10) and living ≥60 miles from the treating facility (aHR 1.20, 95% CI 1.15-1.24).
Conclusions: SDOH are associated with disparities in pediatric cancer survival rates. Targeted strategies to enhance care for Black and Hispanic children, as well as those with limited access due to insurance and travel distance, are essential for achieving equitable outcomes for all pediatric cancer patients.
期刊介绍:
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.